Articles
Linear Capital's eighth anniversary — grateful for the support of our partners. Here's to staying warm, resilient, and always moving forward.
I hope to spend the next eight years—through all its challenges—working alongside kindred spirits to advance frontier tech, frontier productivity, and frontier lifestyle. All for a better society.
A Playbook for Billion-Dollar Drug Development: Navigating Uncharted Waters and Making Landfall | Ronghui
From Prozac to Gleevec — how to persevere on the long and winding road.
Breaking | Saint-Gobain Group's subsidiary, Saint-Gobain PAM China, signs deal with LingShu Intelligence!
In August 2022, **Saint-Gobain PAM China officially launched the first phase of the Linghao Factory production management system,** pushing production efficiency to new heights.
Soaring Across the Global Talent Pool: Ubiquitous Talent and Opportunity Through the Eyes of Global Entrepreneurs | Ronghui
Organizational development at global companies must always stay tightly aligned with the business.
A Conversation with Deel Cofounder Shuo Wang: How the Fastest-Growing SaaS Company in History Manages a Fully Remote Team Across 80+ Countries and 1,300+ Employees
It shattered global SaaS growth records — and our assumptions about what a truly globalized organization could look like.
All exploration and change begin with looking up at the moon | Happy Mid-Autumn Festival
5Y Capital wishes all founders a happy Mid-Autumn Festival!
From Big Pharma to Biotech: Four Industry Leaders on How Innovative Drugs Can Balance Speed and Quality | Ronghui
Speed matters, but getting it right matters more.
Challenger Ventures invested in Alexander Wang, but says consumer spending could still get colder
"I still prefer historical stories to science fiction."
White Rhino Makes a Stunning Debut at the 2022 World Artificial Intelligence Conference, Hailed as a Key Partner for Shanghai Jinqiao Intelligent Connected Vehicle Testing Zone
*https://www.white-rhino.auto*
Linear Capital was named to Cyzone's "2022 Most Admired Early-Stage Investment Firms in China — Top 10."
On September 7, ChinaBang (创业邦) unveiled its "2022 Most Admired VC Firms in China" series of rankings in Wuxi. **Linear Capital was named to the "2022 Most Admired Early-Stage Investment Firms in China TOP 10."** ChinaBang noted that the shortlist was compiled using a combination of submitted data and Ruishou Analysis (睿兽分析) data, with nearly 300 senior investors from outstanding VC firms invited to vote based on each firm's investment track record and post-investment services...